anlotinib alters tumor immune microenvironment by downregulating PD-L1 expression on vascular endothelial cellsShaochuan Liu, Kai Li|Cell Death and Disease|2020Cited by 185
<p>Overexpression of RNF126 Promotes the Development of Colorectal Cancer via Enhancing p53 Ubiquitination and Degradation</p>Shiyang Wang, Kai Li|OncoTargets and Therapy|2020Cited by 16
Immune‐independent acquired resistance to <scp>PD‐L1</scp> antibody initiated by <scp>PD‐L1</scp> upregulation via <scp>PI3K</scp>/<scp>AKT</scp> signaling can be reversed by anlotinibYuan Gao, Kai Li|Cancer Medicine|2023Cited by 13
Genomic alteration profile and <scp>PD‐L1</scp> expression among different breast cancer subtypes in Chinese population and their correlationsKai Li, Ning Liao|Cancer Medicine|2022Cited by 4
Changes in PD-L1 expression on microvessel endothelial cells during melanoma tumor growth and the regulation by anlotinibYingfang Feng, Kai Li|Research Square|2023Cited by 0